Nemedic

Press · Product & platform

Blue Launches Email-Based Prior-Authorization Readiness Agent — No Login Required

Physicians email a clinical note and receive back what is missing for payer approval — with no portal and no change to their workflow.

January 21, 2026

WESTFIELD, Ind. — Nemedic today released two additions to its Blue platform, both built around a single idea: the agent should come to the physician, not the other way around.

The first is a note-analysis agent that works entirely by email. A physician attaches a clinical note, sends it to a dedicated address, and receives a reply identifying the documentation gaps that would put a prior authorization at risk under the relevant payer’s surgical criteria. There is no login, no portal and no new application.

The second turns website form submissions into scheduled patients. When a prospective patient completes a sinus or sleep self-assessment and meets a practice’s criteria, the agent opens a text-message conversation and routes the patient to the practice’s booking link.

“Every portal you ask a busy surgeon to log into is a portal they will stop logging into,” said Bradford G. Bichey, MD, MPH, Nemedic’s founder and chief executive officer. “Email already works.”

Both agents run under a business associate agreement with the practice. Nemedic has a U.S. patent application pending on the patient engagement and documentation methods they use.

About Nemedic, Inc. — Nemedic is a physician-founded healthcare technology company building AI infrastructure and autonomous administrative workflow for procedural healthcare. Its platform, Blue (useBlue.ai), runs alongside existing electronic health records to take on referral intake, patient engagement, prior-authorization readiness and clinical documentation. Nemedic was founded by otolaryngologist Bradford G. Bichey, MD, MPH, and is based in Westfield, Indiana. Its patient engagement and prequalification architecture is protected by U.S. Patent No. 12,592,322. Learn more at useblue.ai.

Media contact: press@nemedic.com